What antibiotics are recommended for treating bacterial gastroenteritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics for Bacterial Gastroenteritis

Empiric antibiotic therapy is not recommended for most cases of bacterial gastroenteritis, as most infections are self-limiting. 1, 2

When to Consider Antibiotics

Antibiotics should only be used in specific circumstances:

  • Infants <3 months of age with suspected bacterial etiology 1
  • Immunocompromised patients with severe illness and bloody diarrhea 1
  • Patients with fever, abdominal pain, bloody diarrhea, and bacillary dysentery (frequent scant bloody stools, fever, abdominal cramps, tenesmus) presumptively due to Shigella 1
  • Recent international travelers with temperatures ≥38.5°C and/or signs of sepsis 1
  • Patients with clinical features of sepsis who are suspected of having enteric fever 1

Recommended Antibiotics by Patient Population

Adults

  • First-line options:
    • Fluoroquinolones (e.g., ciprofloxacin 400 mg IV twice daily or 500 mg PO twice daily) 1
    • Azithromycin 500 mg daily (IV/PO) - especially for areas with high fluoroquinolone resistance 1

Children

  • Infants <3 months: Third-generation cephalosporin (e.g., ceftriaxone) 1
  • Older children: Azithromycin, depending on local susceptibility patterns and travel history 1

Pathogen-Specific Recommendations

Salmonella

  • Uncomplicated diarrhea: Ciprofloxacin 400 mg twice daily IV or 500 mg twice daily PO 1
  • Alternatives: Levofloxacin 500 mg daily PO, amoxicillin 500 mg three times daily PO, or TMP-SMX 160/180 mg twice daily PO/IV 1
  • Bacteremia: Ceftriaxone 2 g daily IV plus ciprofloxacin 500 mg twice daily IV 1

Shigella

  • First-line: Fluoroquinolones (e.g., ciprofloxacin 400 mg twice daily IV or 500 mg twice daily PO) 1
  • Alternative: Azithromycin 500 mg daily IV/PO 1

Campylobacter

  • First-line: Azithromycin 500 mg daily IV/PO 1
  • Alternative: Fluoroquinolones (note: high resistance rates of approximately 19%) 1

Yersinia

  • Diarrhea: Fluoroquinolones (e.g., ciprofloxacin 400 mg twice daily IV or 500 mg twice daily PO) 1
  • Alternatives: TMP-SMX 160/180 mg twice daily PO/IV or doxycycline 100 mg twice daily IV/PO 1
  • Bacteremia: Ceftriaxone 2 g daily IV plus gentamicin 5 mg/kg daily IV 1

Important Considerations and Cautions

  • Avoid antibiotics for STEC O157 and other Shiga toxin 2-producing organisms as they may increase the risk of hemolytic uremic syndrome 1
  • Do not treat asymptomatic contacts of people with bacterial gastroenteritis 1
  • Discontinue antibiotics when a satisfactory clinical response occurs, even if initially untreated pathogens are later reported 1
  • Tailor therapy when culture and susceptibility results become available 1
  • Avoid ampicillin-sulbactam due to high rates of resistance among community-acquired E. coli 1
  • Monitor for antibiotic resistance, which is widespread among enteric pathogens and can quickly spread during epidemics 3

Duration of Treatment

  • Most uncomplicated infections require 3-5 days of treatment 1, 4
  • Severe infections or bacteremia may require longer courses (10-14 days) 1

Follow-up

  • Clinical and laboratory reevaluation may be indicated in people who do not respond to initial therapy 1
  • Consider non-infectious conditions (e.g., IBD, IBS) in patients with symptoms lasting 14 days or more 1
  • Reassess fluid and electrolyte balance and nutritional status in patients with persistent symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Review article: antibiotics and the gut.

Alimentary pharmacology & therapeutics, 1989

Research

Enteropathogens and antibiotics.

Enfermedades infecciosas y microbiologia clinica (English ed.), 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.